Carl Woods, MD
Gastroenterology · Panama City, FLNPI 1174550727
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 192 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 46.5% of the total. Reporting peaked in 2019 at $1,111 and has fallen 94.5% since, to $61 in 2025. That places this record below the midpoint for gastroenterology clinicians in FL, where the typical reported total is $3,025.
Across 192 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$462
- Johnson & Johnson$360
- Pfizer$130
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$129
- Braintree Laboratories, Inc.$104
- plus $600 from 14 others
What the payments were for
- Food & beverage$3,27398%
- Education$672%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 84 | $1,554 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $462 |
| Johnson & Johnson | 18 | $360 |
| Pfizer | 9 | $130 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $129 |
| Braintree Laboratories, Inc. | 6 | $104 |
| Intercept Pharmaceuticals, Inc. | 6 | $88 |
| Evoke Pharma, Inc. | 4 | $85 |
| Redhill Biopharma Inc. | 4 | $68 |
| Daiichi Sankyo Inc. | 3 | $65 |
| Ferring Pharmaceuticals Inc. | 3 | $50 |
| UCB, Inc. | 3 | $42 |
| Boston Scientific | 3 | $42 |
| Nestle Healthcare Nutrition Inc. | 2 | $37 |
| Merck | 2 | $28 |
| Gilead | 2 | $28 |
| Boehringer Ingelheim | 1 | $24 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Dova Pharmaceuticals | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
How this compares
$3,340 in reported general payments places this provider in the 50th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexlansoprazole DrDexlansoprazole | 16 | $3,132 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 32 | $2,226 |
| Pantoprazole Sodium | 76 | $851 |
| Omeprazole | 51 | $815 |
| Dicyclomine Hcl | 15 | $262 |
| Ondansetron Hcl | 25 | $23 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Panama City
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Ronen AraiCoral Springs$1.1M
- Charles SninskyGainesville$983K
- Peter DraganovGainesville$832K
- Arin NewmanMiami Beach$716K
- Joanna LopezMiami$670K
- Jose NietoSebring$573K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.